Medical Training (Prioritisation) Act 2026 – What IMG Doctors Need to Know
If you are an international medical graduate, the Medical Training (Prioritisation) Act 2026 has probably reached you in some form – a headline, a message in a WhatsApp group, a conversation with a colleague who is equally uncertain, or a quiet worry that surfaced while you were in the middle of revision.
Whatever brought you here, you deserve a clear, honest account of what this law actually says. Not the most alarming version. Not the most reassuring version. Just what it says, what it changes, and what it does not change.
This blog does not tell you what decision to make about your career. That is yours, and it depends on your personal circumstances, your stage of training, your immigration status and your goals. What it tries to do is give you an accurate foundation from which to think clearly, at a moment when clarity is genuinely hard to find.
Last updated: June 2026. We will update this page as the guidance develops – particularly around the 2027 changes, which are still being finalised.
What Is the Medical Training (Prioritisation) Act 2026?
The Medical Training (Prioritisation) Act 2026 is a UK law. It was introduced to Parliament on 13 January 2026 and fast-tracked through all parliamentary stages without amendment, receiving Royal Assent on 5 March 2026. The law is in place before the August 2026 training round began.
The Act requires that graduates from UK and Irish medical schools, and certain other defined groups, are given priority access to NHS foundation programme places and specialty training posts. In practice, this means prioritised applicants are offered places first. Non-prioritised applicants – which includes most international medical graduates who do not fall within the defined priority groups – can still apply and can still be offered places, but only once all prioritised applicants have been accommodated.
It is worth understanding where this law came from. The number of applications for NHS specialty training posts rose from around 12,000 in 2019 to nearly 40,000 in 2026, while the number of available posts remained broadly flat. This act is a response to that imbalance, and as part of a commitment to building a more sustainable domestic medical workforce. There are genuine and complex debates about the fairness and implications of that approach, and people hold strong views on both sides. This blog does not adjudicate those debates. What it does is explain what the law requires.
What the Act Does Not Change
This is where many doctors searching for information need the most help, because the most common misreading of this Act is the belief that it closes the door entirely for international medical graduates. It does not.
PLAB 1 and PLAB 2 are unchanged. The Act has no effect on the PLAB pathway or the GMC registration process. If you are currently preparing for PLAB 1 or PLAB 2, or if you have recently passed one of them, the exam itself and the registration process that follows remain exactly as they were.
Read our complete guide for UKMLA PLAB 1 here.
Read our complete guide for UKMLA PLAB 2 here.
GMC registration is unchanged. Passing PLAB 1 and PLAB 2 still leads to GMC registration and a licence to practise medicine in the UK. A GMC licence allows you to work across a wide range of NHS roles.
Non-training NHS posts are unchanged. Trust grade posts, locally employed doctor roles, clinical fellow positions and specialty doctor roles are not part of the foundation programme or specialty training system and are not covered by this Act. The NHS continues to employ international medical graduates in these posts, and many doctors build substantial careers through these routes.
The MSRA is unchanged. The exam itself is unaffected. International medical graduates can still sit the MSRA as part of specialty training applications. What the Act affects is the order in which offers are then made, not the exam itself.
Read our complete guide for MSRA here.
University-based postgraduate programmes are unchanged. Academic degrees offered by UK universities – clinical fellowships, research posts, postgraduate qualifications – are entirely outside the scope of this Act and are unaffected.
What Has Actually Changed
The Act changes the structure of how places are offered for the foundation programme and specialty training posts.
For the foundation programme from 2026, places must be offered first to prioritised applicants. It is worth noting that historically very few international medical graduates – typically in the range of 50 to 100 per year – have entered the NHS through the central UK Foundation Programme, since most IMGs enter via direct trust appointment after achieving GMC registration. That established route through direct NHS employment is not affected by this Act.
Read our complete guide for the UK Foundation Programme here.
For specialty training posts with August 2026 start dates, prioritisation was applied at the offer stage. Because shortlisting for 2026 posts was already underway when the Act passed, offers were made first to prioritised applicants, with non-prioritised applicants considered only if places remained.
From the autumn 2026 application round for posts starting in August 2027, prioritisation will apply from the shortlisting stage through to offers – not just at the final offer stage. This is a more significant shift, and it is the change most doctors asking questions right now need to understand. From 2027, non-prioritised applicants may not reach interview if enough prioritised applicants are available. The exact definition of “significant NHS experience” – which will determine whether IMGs already working in the NHS qualify for priority status from 2027 – is still being developed through consultation with stakeholders. NHS England has committed to confirming this definition before the autumn 2026 recruitment round opens.
The Government also committed to creating 1,000 additional specialty training posts in England, with applications opening from April 2026. The BMA has been clear that this falls well short of what is needed to resolve the overall shortage of posts, but it represents some expansion of the total pool available.
Who Is in a Priority Group?
For specialty training posts with 2026 start dates, the following groups are prioritised, as confirmed by NHS England and the Act itself:
– Doctors holding a primary medical qualification from a UK or Republic of Ireland medical school
– Doctors holding a primary medical qualification from medical schools in Iceland, Liechtenstein, Norway or Switzerland (under existing reciprocal professional agreements)
– Doctors who have completed or are currently on a relevant qualifying UK training programme (for example, a foundation doctor applying for core training, or a core trainee applying for higher specialty training)
– For 2026 only, as a temporary proxy for significant NHS experience: doctors who are British or Irish citizens, Commonwealth citizens with the right of abode, those with indefinite leave to enter or remain in the UK, or those with EU settled status under the EU Settlement Scheme
The immigration status categories listed above apply for 2026 only. From 2027, these are expected to be replaced by a definition of “significant NHS experience” that is still being finalised.
If you are uncertain whether you fall within a priority group, the NHS England guidance page on the Act and the BMA’s frequently asked questions are the most accurate sources to check. Individual circumstances can be complex, and a brief summary cannot substitute for reading the primary guidance directly.
Why So Many Doctors Are Finding This Hard to Process
It would be wrong to move past the human dimension of this without acknowledging it properly.
For a significant number of international medical graduates, this Act arrived after years of work, financial sacrifice, difficult examinations, and careful planning. Some doctors were mid-way through PLAB preparation. Some had passed both PLAB 1 and PLAB 2, achieved GMC registration, and were already applying for NHS posts. Some had relocated to the UK, or were in the process of doing so. For those doctors, the March 2026 headlines did not feel like a policy update. They felt like a fundamental disruption to plans that had taken years to build.
That response is understandable. It is not an overreaction.
Policy changes of this kind, implemented rapidly and applied to an active recruitment cycle, create real uncertainty. The feelings that follow – anxiety, a sense of unfairness, confusion about what to do next – are legitimate.
What tends not to serve those feelings well is making major life decisions in their grip, based on the most alarming version of events. The landscape here is more nuanced than many early headlines suggested, and some of the most important details – particularly around 2027 – are still being finalised. That is not a reason for complacency. It is a reason for getting accurate information before drawing conclusions.
Questions Doctors Are Currently Asking
Is PLAB still worth doing?
PLAB remains the established route to GMC registration for international medical graduates. GMC registration gives you the right to practise medicine in the UK and access a wide range of NHS employment. What has changed is the competitive landscape for formal specialty training posts specifically. Whether that affects your individual situation in a meaningful way depends on what you are aiming for, where you are in the pathway, and what your long-term plans look like. That assessment is yours to make – but it is best made with accurate information rather than panic.
Understand UKMLA PLAB 1 here.
Understand UKMLA PLAB 2 here.
Can I still get an NHS job as an IMG?
Non-training NHS posts – trust grade, clinical fellow, locally employed doctor, specialty doctor – are not affected by this Act. The NHS continues to recruit international medical graduates into these roles. The change in prioritisation applies to formal foundation programme and specialty training posts specifically.
Does this affect the MSRA?
The MSRA exam is unchanged. IMGs who need to sit it can still do so. The Act affects how offers are made after the process concludes, not the exam itself. That said, the change to shortlisting from 2027 means that for some specialties, non-prioritised applicants may not reach the stage at which MSRA scores are fully used – which is why understanding your priority status matters.
Understand the MSRA exam here.
Does this affect IMGs already working in the NHS?
This depends on your immigration status and training history. Doctors already in the UK who hold ILR, EU settled status, British citizenship, or who have completed UK foundation or core training may already fall within a priority group. From 2027, “significant NHS experience” is expected to create an additional route to priority status for IMGs already embedded in the NHS. The definition of that phrase is still being confirmed. If this applies to you, it is worth watching NHS England guidance closely over the coming months.
What about the extra training posts?
The Government has committed to 1,000 additional specialty training posts in England, with applications opening from April 2026. This does not resolve the wider shortage – the BMA has made that clear – but it does add to the total number of places available. Further information is available through NHS England and the specialty recruitment pages.
Will there be legal challenges?
Commentary from various organisations has drawn parallels with earlier cases involving changes to IMG recruitment, and potential legal challenges have been discussed. This is a live area. For the most current information, the BMA and BAPIO are the appropriate organisations to follow. This blog will be updated if significant legal developments change the picture.
Thinking Clearly About What Comes Next
If you are an international medical graduate trying to work out what this means for your own situation, the following may help orient your thinking – without telling you what conclusion to reach.
Understand your own position before drawing conclusions. Your immigration status, whether you have existing UK training, which specialty you are aiming for, and how far along the PLAB pathway you are will all affect how this Act applies to you personally. The picture looks very different for an IMG with ILR already working in an NHS trust than it does for someone yet to sit PLAB 1 in their home country.
Read official sources directly. The NHS England pages on this Act, the BMA’s frequently asked questions, and specialty-specific recruitment guidance are the most reliable starting points. Secondary summaries – including this one – can help you understand the landscape, but they should not be the basis for significant decisions. Primary guidance is always the right reference point.
Be careful about decisions made under acute stress. The headlines around this Act have often been starker than the law itself, and some of the most widely shared commentary has not distinguished carefully between what has changed for 2026 and what is being planned for 2027. These are meaningfully different. Take the time to understand which applies to your situation.
If you are mid-preparation for PLAB, consider carefully before stopping. The clinical knowledge and skills you are building, and the GMC registration you are working towards, have value across a range of NHS roles, not only formal specialty training. Stopping preparation out of fear is a different thing from making a considered, informed decision to change direction. Only you can judge which one would apply to your situation.
A Note on This Page
The Medical Training (Prioritisation) Act 2026 is not a settled, static picture. The definition of “significant NHS experience” for 2027 is still being developed. The consultation NHS England has committed to running with stakeholders is still to conclude. The additional training posts commitment is still being implemented. Legal commentary continues to evolve.
We will update this blog when meaningful changes occur. The date at the top of the page reflects when it was last reviewed. If you are reading this some time after publication, please check whether the guidance has moved on – and always verify the most current position through official NHS England and GMC sources.
Author Bio - Dr Aman Arora
Hi! I’m Dr. Aman Arora, a Portfolio GP with over a decade of clinical and teaching experience, dedicated to helping doctors achieve their goals with confidence. Having had the privilege of supporting more than 50,000 doctors worldwide across exams such as MRCGP AKT, SCA, MSRA, PLAB 2 and PLAB 1, I understand the challenges you face and the strategies needed to overcome them. Through personalised face-to-face sessions, engaging online courses, mocks, audio and a vibrant social media community, we’re here to guide you every step of the way.
Whether you’re looking to pass crucial exams or take the next big step in your medical career, we’re here to help you succeed. Feel free to get in touch with any thoughts, questions, or ideas — I look forward to working with you and being part of your journey.
Author Bio - Dr Pooja Arora
Dr Pooja Arora is a GP with a background in Medical Politics, where she passionately focuses on improving the opportunities and working conditions for junior doctors. She is proud to hold FRCGP (Fellow of Royal College of General Practitioners).
You can find out more about Pooja’s previous roles and qualifications here.
